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Wnt/β-catenin signaling pathway 
safeguards epigenetic stability and 
homeostasis of mouse embryonic 
stem cells
Ilda theka1, Francesco sottile1, Marco Cammisa2,3, sarah Bonnin  1, Marta sanchez-
Delgado  4, Umberto Di Vicino1, Maria Victoria Neguembor1, Karthik Arumugam1, 
Francesco Aulicino1, David Monk4, Andrea Riccio2,3 & Maria pia Cosma1,5,6
Mouse embryonic stem cells (mESCs) are pluripotent and can differentiate into cells belonging to 
the three germ layers of the embryo. However, mesC pluripotency and genome stability can be 
compromised in prolonged in vitro culture conditions. several factors control mesC pluripotency, 
including Wnt/β-catenin signaling pathway, which is essential for mESC differentiation and 
proliferation. Here we show that the activity of the Wnt/β-catenin signaling pathway safeguards normal 
DNA methylation of mesCs. the activity of the pathway is progressively silenced during passages 
in culture and this results into a loss of the DNA methylation at many imprinting control regions 
(ICRs), loss of recruitment of chromatin repressors, and activation of retrotransposons, resulting into 
impaired mESC differentiation. Accordingly, sustained Wnt/β-catenin signaling maintains normal ICR 
methylation and mesC homeostasis and is a key regulator of genome stability.
The evolutionarily conserved Wnt/β-catenin signaling pathway controls many cellular and developmental 
processes, including cell proliferation, cell fate determination and tissue homeostasis1. Mutations affecting the 
Wnt/β-catenin pathway often lead to disease, cancer progression and developmental defects.
The canonical Wnt/β-catenin-dependent pathway integrates membrane, cytoplasmic and nuclear compo-
nents, such as Wnt ligands, Frizzled (FZD) receptors and co-receptors, AXIN/glycogen synthase kinase 3 (GKS3)/
Adenomatosis polyposis coli (APC)/Casein Kinase I (CKI) destruction complex, β-catenin protein and several 
transcription factors1,2. In the absence of Wnt ligands, cytoplasmic β-catenin is constantly degraded by the action 
of the AXIN/GSK3/APC/CKI destruction complex. On the contrary, the destruction complex is disassembled 
when Wnt ligands bind to the FZD receptors. As a consequence, β-catenin translocates to the nucleus where it 
associates with TCF/LEF (T-cell factor/lymphoid enhancing factor) nuclear complex and activates Wnt targeted 
gene expression3.
During embryogenesis Wnt/β-catenin signaling plays a fundamental role in the establishment of both dorso-ventral 
and anterior-posterior axis and its role is essential for normal gastrulation. Indeed, β-catenin knockout embryos 
are lethal since they fail to develop the mesodermal and endodermal germ layers4,5. Accordingly, Wnt/β-catenin 
represents a key pathway for mouse embryonic stem cell (mESC) identity and homeostasis.
Mouse ESCs, derived from the inner cell mass (ICM) of the blastocyst6,7 are pluripotent stem cells, which are 
able to generate the three germ layers and can be expanded in vitro indefinitely. Their long-term self-renewal 
ability has been attributed to the protein regulatory network that includes several pluripotency factors, such as 
Nanog, Oct4 and Rex1, among others8–11. In this context, the role of β-catenin during mESC differentiation has 
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been shown to be indispensable, since β-catenin null mESCs undergo apoptosis at the onset of the differentia-
tion process12–14. However β-catenin function in ESC self-renewal has been largely debated14–20. The dual role 
of β-catenin can be attributed to its capacity to form complexes with many downstream factors, including key 
pluripotency genes, such as Oct421,22.
In parallel to the core pluripotency factors, several epigenetic mechanisms control mESC identity through 
chromatin remodeling processes23. In particular, reversible changes on DNA methylation, followed by histone 
modifications, control both pluripotency and differentiation genes in mESCs, recapitulating the epigenetic profile 
of the pre-implantation embryo stage24,25. While developmental genes are characterized by flexible and reversible 
epigenetic regulation mechanisms to allow their dynamic expression, stable DNA methylation ensures silencing 
and protection of retrotransposons from moving around in the genome and causing potential mutations26. The 
same applies to imprinted genes, which reside in clusters27 and are regulated from one major cis-acting element 
called the imprinting control region, ICR. In mammals, DNA methylation is maintained stable and it can be 
propagated through cell division28–30 by a mechanism of DNA methylation maintenance coupled to DNA repli-
cation, which involves the action of different enzymes including DNA methyltransferase I (DNMT1). Along with 
DNA methylation, other epigenetic factors, such as ZFP57, KAP1, DNMT1, H3K9me3 and others, are involved in 
marking the ICRs and in protecting the methylated DNA. Indeed, loss of ZFP57, KAP1, DNMT1 or other repres-
sors, leads to loss of imprinting and genomic instability in mESCs, and, thereby, to embryonic lethality27,31–34.
Epigenetic instability in imprinted genes and transposons has been observed in several mESC lines and can be 
attributed to culture conditions, sex of the cells, isolation procedures35 or prolonged in vitro culture of mESCs36–39. 
In particular, mESCs with global loss of methylation at the ICRs have been shown to contribute to chimeras, but 
mice developed several types of tumors by one year of age40. The mechanisms causing genomic aberrations and 
destabilization are still debated. However, downregulation of several epigenetic factors, such as DNMT1, KAP1, 
G9a, has been correlated with the epigenetic instability of the cells34,41–46.
Mouse embryonic stem cells represent an essential model to study in vitro the mechanisms that regulate 
embryo development. Therefore, it is important to fully understand the mechanisms that control cell identity, 
genomic stability and cell homeostasis. Wnt/β-catenin signaling has been investigated to be crucial for gene tran-
scriptional regulation of mESCs, including pluripotency genes. Though, the connection between Wnt signaling 
and the epigenetic regulatory mechanisms has not been elucidated up to now. Here we investigated a novel role of 
Wnt/β-catenin signaling as a key player involved in epigenetic changes that preserve mESC identity and genome 
stability. We found that mESCs cultured in vitro for prolonged time showed loss of Wnt activity and downregula-
tion of β-catenin protein, which correlated with a general loss of DNA methylation, affecting the ICRs, and lead-
ing to impaired mESC differentiation. On the contrary, sustained levels of Wnt/β-catenin ensure ICR methylation 
maintenance over time, suggesting a possible role for this signaling pathway in the protection of silent genomic 
regions and, therefore, in the maintenance of the genomic stability.
Results
Wnt/β-catenin activity is downregulated in mesCs after prolonged in vitro culture. The 
functional role of the Wnt/β-catenin pathway has been widely investigated in pluripotent stem cells. While the 
activation of Wnt pathway is indispensable for mouse embryonic stem cell (mESC) differentiation, its role in 
self-renewal and cell identity maintenance has been largely debated. Thus, we decided to analyze the activity of 
the Wnt/β-catenin pathway in mESCs cultured for a prolonged time, in particular its influence on pluripotency 
and homeostasis, including cell proliferation, differentiation potential and epigenetic stability.
To this aim we cultured E14 mESCs for several passages in the Serum + LIF medium. We observed that E14 
mESCs cultured for many passages, around seventy, (old passage mESCs, henceforth called OP-mESCs), showed 
homogeneous morphology, characterized prevalently by flat clones, when compared to the same mESCs that 
were kept in culture for only fourteen passages (young passage mESCs, henceforth called YP-mESCs) (Fig. 1a,b). 
Similar results were obtained with GS1 mESCs, derived from a different strain, that were grown in prolonged cul-
ture conditions (around fifty passages, OP-mESCs) (Fig. S1a,b). In contrast, both E14 and GS1 YP-mESC cultures 
displayed heterogeneous morphology, including both round shaped and flat morphology clones (Figs 1b and 
S1b, upper panels). Pluripotent cell heterogeneity is due to fluctuation of pluripotency marker expression within 
the cell population. Even though cell heterogeneity can be found in almost all pluripotent stem cells, including 
induced pluripotent stem cells, the mechanisms causing gene expression variability and changes in morphology 
are still under investigation47–53.
Interestingly, both E14 and GS1 OP-mESCs showed low Wnt activity, since the Wnt targets Axin2, Lef1, Tcf1 
and Sp5 were significantly downregulated, when compared to YP-mESCs (Figs 1c and S1c). In addition, total 
β-catenin protein was downregulated in E14 and GS1 OP-mESCs, as indicated by the microscope fluorescence 
intensity (Figs 1d–e and S1d,e). Additionally, by western blot analysis we observed lower amount of both total 
and nuclear β-catenin protein in OP-mESCs when compared to YP-mESCs (Figs 1f and S1f), suggesting again a 
reduction in the canonical Wnt/β-catenin signaling activity in OP-mESCs.
The difference in morphology of OP-mESCs did not correspond to significantly altered pluripotency gene 
expression. In particular, we compared the expression of NANOG and OCT4 protein levels among OP-mESCs 
and YP-mESCs for both E14 and GS1 strains (Figs 1g–i and S1g,i). We did not find any relevant difference in the 
expression pattern (Figs 1g and S1g) or significant changes in the protein level of NANOG and OCT4 (Figs 1h,i and 
S1h,i) among YP- and OP-mESCs. Thus, YP- and OP-mESCs expressed comparable levels of NANOG and OCT4.
Moreover, we performed FACS analysis to detect protein expression of the pluripotency cell membrane markers 
E-cadherin and SSEA154–59. The expression of E-cadherin was similar between YP- and OP-mESCs in both cell lines 
(Figs 1j,k and S1j,k). The percentage of cells expressing SSEA1 was higher in OP-mESC E14 (Fig. 1l,m), but did not 
change in GS1 mESCs (Fig. S1l,m). These data further confirmed that the pluripotency genes were not downregu-
lated after prolonged culturing or even they were slightly upregulated in OP cells, as in the case of E14 mESCs.
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Figure 1. Prolonged in vitro cell culture of E14 mouse embryonic stem cells (mESCs) correlates with low Wnt/β-
catenin activity. (a) Schematic representation of Young (YP) and Old passage (OP) E14 mESCs. (b) Representative 
bright field images of YP- and OP-mESCs. Round-shaped and flat colonies are indicated by white and yellow 
arrow, respectively. (c) Quantitative real-time PCR showing the expression profiles of Axin2, Lef1, Tcf1, Sp5 in 
YP- and OP- mESCs. The transcriptional levels are normalized to Gapdh as reference gene. Data are represented 
as fold change (2−ΔΔCt) relative to the YP-E14 mESCs and means of n = 3 independent experiments ± SE. (d,e) 
Representative immunofluorescence (d) and confocal microphotographs (e) of β-catenin. Nuclear demarcation 
is indicated by white circles (right panel). (f) Western blot analysis showing total and nuclear β-catenin protein 
in YP- and OP-mESCs and its quantification (n = 1) relative to total β-catenin in YP-mESCs. For quantification, 
densitometric analysis was performed with ImageJ software. The quantification reflects the relative amounts as 
a ratio of each protein band relative to their loading control. (g) Representative immunofluorescence images 
showing OCT4 (green), NANOG (red) and their merge in YP- and OP-E14 mESCs. (h,i) Representative western 
blot analysis of OCT4 and NANOG in YP- and OP-mESCs (h) and its quantification represented as fold change 
over the protein amount in YP-mESCs and means of n = 3 independent experiments ± SE (i). (f,h,i) Full scan 
blots are available in Supplementary Fig. 6. (j–m) FACS-plot showing the percentage of E-cadherin +(j) and 
SSEA1 +cells (l) in YP- and OP- mESCs and its quantification (k,m) as means of 3 technical replicates ± SE (NS: 
non stained). (n,o) Representative cell cycle FACS profile analyzed with Flowjo software (n) and its quantification 
(o) represented as percentage of total cells and means of n = 3 independent experiments ± SE. Scale bar is 200 
(b,d,g) and 10 μm (e). (d,e left panel, and g) Nuclei were stained with DAPI. (f,h) β-tubulin and H3 were used 
as loading controls. (c,i,k,m,o) Asterisks indicate statistical significance calculated by unpaired two-tailed t test 
analysis (n.s. not significant; *p-value < 0.05; ***p-value < 0.001).
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Since prolonged in vitro culturing39,60 and Wnt/β-catenin activity61 can affect cell proliferation, we com-
pared cell cycle progression in both YP- and OP-mESCs. Both E14 and GS1 OP-mESCs displayed a significantly 
lower percentage of cells in G1 phase in comparison with the YP-mESCs (Figs 1n,o and S1n,o). Moreover, E14 
OP-mESCs also showed a significant increase in the number of cells in G2/M phase, with respect to the YP-mESCs 
that on the contrary, displayed a higher number of cells in G1 and S phases (Fig. 1n,o). Overall, these data suggest 
that OP-mESCs are characterized by higher proliferation rate along with Wnt signaling down-regulation.
Wnt signaling and β-catenin protein are essential for differentiation and cell fate determination12–14,20,62. Thus, 
we induced embryoid body (EB) formation from both E14 and GS1 YP- and OP-mESCs (Figs 2a and S2a) to 
evaluate their differentiation capacity. EBs can recapitulate in vitro many aspects of cell differentiation that occur 
during early embryogenesis63. Interestingly, even though all the mESCs that we used could form normal aggre-
gates in suspension (Figs 2b and S2b, left panels) only YP-mESCs were able to generate beating EBs (Movies S1, 
S2) and to form large three-dimensional multicellular structures (Figs 2b and S2b, right and upper panel). In con-
trast, OP-mESCs gave rise to small structures, and we did not observe any beating EBs (Movies S3, S4) up to day 
9 (Figs 2b and S2b, right and lower panels). We further characterized the EBs by analyzing transcriptional levels 
of genes corresponding to the three germ layers at day 6 (D6) and 12 (D12) of differentiation. For this we used 
undifferentiated YP- and OP-mESCs as controls (ESC). In particular, EBs derived from E14 or GS1 OP-mESCs 
showed lower level of the mesodermal marker Nkx2.5 already at day 6 with respect to the YP-mESCs, while the 
endoderm marker Gata6 was significantly downregulated only at day 12 of EB differentiation (Figs 2c and S2c). 
These results were consistent with already published studies, which reported that Wnt/β-catenin pathway activity 
is essential for mesoendoderm specification12,62. On the other hand, the ectodermal marker Otx2 was significantly 
upregulated in OP cells already at the mESC stage and it further increased with differentiation, being expressed 
at much higher level in OP-EBs with the respect to YP-EBs. This result suggests that the differentiation could be 
biased toward ectoderm (Figs 2c and S2c), which was confirmed when we induced neural differentiation64,65 of 
both YP- and OP-mESCs (Figs 2d and S2d). Indeed, OP-mESCs expressed higher levels of Sox1, when compared 
to YP-mESCs and this was also the case at day 3 of neural differentiation (Figs 2e and S2e). We confirmed these 
results by analyzing the expression of other neural markers at day 8 (D8) of differentiation, such as Nestin and III 
β –tubulin (TUJ1) and Pax6 (Figs 2f–g and S2f,g). OP-mESCs expressed higher level of Nestin and III β –tubulin 
(TUJ1) protein at day 8 (D8) of neural differentiation, with respect to YP-mESCs, in both cell lines (Figs 2f and 
S2f). Moreover, both Nestin and III β –tubulin (TUJ1) positive cells obtained from OP-mESCs were characterized 
by a more branched and elongated morphology, suggesting a faster neural differentiation (Figs 2f and S2f). Pax6 
was upregulated in OP-mESC, in both E14 and GS1 (Figs 2g and S2g, left plot) and although Fgf5 was upregulated 
in E14 OP- neural precursors, it showed lower levels in differentiated GS1 OP-mESCs compared to their YP coun-
terpart (Figs 2g and S2g, right plot). Surprisingly, although similar levels of pluripotency genes were expressed 
in both YP- and OP-mESCs, during differentiation the levels of Rex1, Oct4 and Nanog, remained much higher 
in OP-EBs with respect to the YP-EBs (Figs 2c and S2c, lower plots). These data suggest that the differentiation 
potential of mESCs, in particular toward the meso-endodermal germ layers, is strongly impaired in prolonged 
culture condition, and correlates with high level of pluripotency genes in both OP-mESCs and OP-EBs.
Reduced activity of Wnt/β-catenin signaling in op-mesCs correlates with loss of DNA meth-
ylation, affecting also ICRs. Several epigenetic alterations causing DNA methylation changes have been 
associated with prolonged in vitro cell culture36. In pluripotent stem cells, DNA methylation regulates many cel-
lular processes including cell differentiation. Altered DNA methylation has often been associated with impaired 
differentiation capacity of mESCs44. In this context, Wnt/β-catenin pathway regulates pluripotent stem cell 
differentiation, however its involvement in DNA methylation has not been explored. We, therefore, wondered 
whether OP-mESCs, which express low level of β-catenin protein and Wnt target transcripts, could show any 
change in DNA methylation levels. Thus, we performed Reduced Representation Bisulfite Sequencing (RRBS), 
a technique that combines restriction enzymes and bisulfite sequencing to enrich for the genomic areas with 
high CpG content66, using both YP- and OP-mESCs. Only 3 genomic regions, localized close to Repin1, Nkx2-1 
and Gm11846 genes, were hypermethylated in E14 OP-mESCs after prolonged culture, when compared to the 
YP-mESCs (Table S1). In contrast, we found a general hypomethylation in E14 OP-mESCs. Indeed, about 100 
genomic CpG-rich regions displayed reduced DNA methylation in OP-mESCs with respect to YP-mESCs (Fig. 2h 
and Table S1). The coding genes nearby these hypomethylated genomic regions belong to different gene fami-
lies and they control several biological processes, including metabolic and developmental processes, as analyzed 
by PANTHER functional classification (Fig. 2i). Among the list of hypomethylated regions we found several 
imprinted genes. Imprinted genes have been previously described to be crucial for metabolic and developmental 
process regulation67,68. In particular, the ICRs corresponding to Plagl1, Grb10, Impact, Igf2r and Peg10 loci showed 
reduced DNA methylation in many CpGs in OP-mESCs but not in YP-mESCs (Fig. 2h). ICRs control many ele-
ments within the imprinted clusters and they have been shown to be generally stable in the pre-implantation 
embryo, and to be methylated in only one allele27,32. By analyzing only ICRs, we observed that YP-mESCs showed 
a normal profile of DNA methylation (around 50%, corresponding to one specific allele), while methylation was 
lost in several ICRs in OP-mESCs (Fig. 2j). Our results indicate that impairment of the ICR status, such as loss of 
DNA methylation, can affect pluripotency and differentiation potential of mESCs40.
To validate the RRBS data and to examine the methylation profile of additional ICRs, we performed Combined 
Bisulfite Restriction Analysis (COBRA) coupled to pyrosequencing analysis. Methylation analysis by COBRA 
includes the use of methylation sensitive restriction enzymes that can digest DNA only when methylated. As 
expected, some of the ICRs were hypomethylated in OP-mESCs and not in YP-mESCs, such as Airn, Rasgrf1, 
Peg10 and Grb10, as shown by the enzymatic digestion pattern (Fig. S2h). On the contrary Ig-DMR and Gnas XL 
did not show differences in DNA methylation (Fig. S2h). In parallel, we also included genomic DNA extracted 
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Figure 2. Old passage E14 mESCs show differentiation defects and loss of methylation at ICRs. (a) Schematic 
representation of embryoid body (EB) differentiation protocol of YP- and OP- mESCs. (b) Representative 
bright field images showing EBs at day 4 (D4) and 9 (D9) obtained from both YP- and OP- E14 mESCs. Scale 
bar is 400 μm. (c) Quantitative real-time PCR showing the expression profiles of differentiation genes (Nkx2.5, 
Gata6, Otx2) and pluripotency genes (Rex1, Oct4, Nanog) in YP- and OP- E14 mESCs (ESC) and during 
EB differentiation at day 6 (D6) and day 12 (D12). (d) Schematic representation of neural differentiation 
protocol of YP- and OP- mESCs. (e) Quantitative real-time PCR showing the expression profiles of Sox1 at 
day 3 (D3) of N2B27 + retinoic acid (RA) treatment in YP- and OP-E14 mESCs (ESC). (f) Representative 
immunofluorescence images showing Nestin (left panels) and III β-tubulin (TUJ1, right panels) protein 
expression in YP- and OP- mESCs at day 8 (D8) of neural differentiation. (g) Quantitative real-time PCR 
experiment showing the expression profiles of Pax6 and Fgf5 at day 8 (D8) of N2B27 + retinoic acid (RA) 
treatment in YP- and OP- E14 mESCs (ESC). (c,e,g) The transcriptional levels are normalized to Gapdh as a 
reference gene. Data are represented as fold change (2−ΔΔCt) relative to the YP-E14 mESCs and the results are 
means of n = 3 independent experiments ± SE (c,e) and means of n = 3 technical replicated for SD (g). (c,e) 
Asterisks indicate statistical significance calculated by unpaired two-tailed t test analysis (n.s. not significant; 
*p < 0.05; **p < 0.01; ***p-value < 0.001). (h) Number of hypomethylated common CpGs in OP- versus YP- 
E14 mESCs analyzed by RRBS covered by at least 10 reads and showed at least 25% of methylation reduction. 
Red rectangle indicates imprinted regions. (i) Gene ontology of hypomethylated regions in OP-E14 mESCs 
analyzed by PANTHER (www.pantherdb.org). (j) Box-plot, from min–max values, showing the distribution 
of mCpG levels at ICRs in YP- and OP-E14 mESCs determined by RRBS analysis. The plots indicate the first 
quartile, median (black line) and third quartile. Data are obtained from the average of n = 2 biological replicates.
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from a wild type mouse (Ctrl gDNA) as a positive control, carrying a normal methylation profile, and from Zfp57 
knockout mESCs (Zfp57 KO) that have been shown to lose methylation at several ICRs34.
Finally, to quantify the DNA methylation changes observed by COBRA, we performed pyrosequencing anal-
ysis. Even in this case, E14 YP-mESCs showed normal levels of DNA methylation (around 50%) at the analyzed 
ICRs (Airn, Rasgrf1, Peg10, Grb10, Ig-DMR and Gnas XL) that was comparable to the mouse genomic DNA (Ctrl 
gDNA) (Fig. S2i). On the contrary, OP-mESC methylation profile was similar with that of Zfp57 KO mESCs, as 
Airn, Rasgrf1, Peg10 and Grb10 had less than 20–30% of methylation. However, no changes were detected with 
passages in Ig-DMR and Gnas XL ICRs (Fig. S2i). In addition, by performing bisulfite-PCR sequencing we also 
observed loss of methylation at several CG dinucleotides in both KvDMR (also called Kcnq1) and Inpp5fV2 ICRs 
in E14 OP- but not in YP-mESCs (Fig. S2j). The KvDMR ICR was hypomethylated also in the GS1 OP-mESCs 
when compared to YP-mESCs (Fig. S2j,k left). However, the Inpp5fV2 ICR was already hypomethylated in the 
GS1 YP-mESCs and did not show any further loss of methylation with passages (Fig. S2k, right).
Overall these data indicate that downregulation of endogenous Wnt signaling and of β-catenin protein level 
occurs in prolonged mESC cultures and this correlates with loss of DNA methylation. In particular, we observed 
loss of methylation at several ICRs, including both maternally and paternally methylated loci that, in turn, control 
the expression of a variety of coding and non-coding genes within the imprinted clusters.
Wnt/β-catenin activity “protects” the ICRs against de-methylation. To further investigate the 
implication of Wnt/β-catenin signaling in the control and protection of the ICRs against de-methylation, we 
generated two Wnt signaling mutant mESC clones overexpressing the S33Y-mutated β-catenin protein in E14 
YP-mESCs. This β-catenin protein mutant is stable since it is not recognized and degraded by the AXIN/GSK3β/
APC/CKI destruction complex and it is retained in the nucleus69,70. We named the two E14-derived mESC clones, 
carrying the S33Y-mutant β-catenin protein, S33Y-β-cat #1 and S33Y-β-cat #2. To test if sustained Wnt/β-catenin 
signaling activity could preserve methylation at ICRs, we cultured the clones in the conditions that were used to 
derive E14 OP-mESCs (Fig. 3a). We next tested the level of Wnt signaling by analyzing the activity of the topflash 
reporter (7TGP)71 in the old passage ESC clones (OP-S33Y-β-cat #1 and OP-S33Y-β-cat #2) and we compared 
them with both E14 YP- and OP-mESCs. OP-S33Y-β-cat #1 and OP-S33Y-β-cat #2 retained high level of Wnt 
activity as indicated by the top-flash reporter (Fig. 3b) and by high expression of Axin2 (Fig. 3c). Since the 7TGP 
lentiviral vector carries a puromycin resistance cassette, prior to the Wnt activity analysis we selected the infected 
cells to ensure homogeneous expression of the reporter within the cell population in each condition. In parallel, 
to test the topflash reporter reliability we treated E14 mESCs with either DMSO or CHIR (3 μM) for 24 hours 
as previously reported15,72. As expected, the 7TGP reporter was activated upon CHIR but not DMSO treatment 
(Fig. S3a). Moreover, total β-catenin protein was maintained at similar level as in E14 YP-mESCs, rather than 
being downregulated as in E14 OP-mESCs (Fig. 3d).
Next, we tested the methylation status of OP-S33Y-β-cat #1 and OP-S33Y-β-cat #2 mutant clones by per-
forming RRBS analysis and compared the mutant clones with both E14 YP- and OP-mESCs. The clusters and 
PCA analysis grouped together E14 YP-mESCs, OP-S33Y-β-cat #1 and OP-S33Y-β-cat #2 (Figs 3e and S3b), but 
not E14 OP-mESCs, which clusterized apart. In addition, the two replicates belonging to each sample perfectly 
correlated between them (Fig. S3c). As expected, OP-S33Y-β-cat #1 and OP-S33Y-β-cat #2 clones maintained 
the methylation at the ICRs at around 50%, indicating allele-specific methylation (Fig. 3f). Moreover, by plotting 
together all the conditions it was clear that E14 OP-mESCs showed loss of methylation at many ICRs if compared 
to YP-mESCs and to the mutant clones (Fig. 3g).
To further validate the RRBS data and to analyze additional ICRs, we performed COBRA analysis and 
pyrosequencing quantification (Fig. S3d,e). Methylation at Airn, Rasgrf1, Grb10 and Ig-DMR ICRs was main-
tained normal, at around 50%. However, in the OP-S33Y-β-cat #2 clone Gnas XL and Peg10 were hypermeth-
ylated and hypomethylated respectively, suggesting other possible and unpredictable cellular mechanisms, or 
perturbations occurring in specific clones that could be induced by selection effects. Finally, OP-S33Y-β-cat #1 
and OP-S33Y-β-cat #2 mESC clones maintained a round shaped morphology also after several passages in vitro 
(Fig. S3f).
Overall these data indicate that sustained Wnt/β-catenin activity in mESCs cultured for several passages in 
Serum + LIF medium prevents the loss of methylation at ICRs and at other genomic regions. Accordingly, loss of 
Wnt activity can affect DNA methylation and, as a consequence, mESC differentiation potential.
DNA hypomethylation results in loss of chromatin repressor recruitment at the ICRs. To pro-
tect the methylated allele from de-methylation, several chromatin repressors are recruited at the ICRs. In par-
ticular, ZFP57 is highly expressed in mESCs and can directly bind to a methylated hexanucleotide DNA motif 
within imprinted control regions34. After binding, ZFP57 recruits KAP1, which in turn interacts with other 
heterochromatin-associated histone marks, including H3K9me333,34. Thus, we decided to investigate whether 
ZFP57 and H3K9me3 levels changed during mESC passages along with the loss of DNA methylation at the 
ICRs. To this aim, we performed chromatin immunoprecipitation (ChIP)-qPCR experiments for both ZFP57 
and H3K9me3 on some known ICR target regions34. Both ZFP57 and H3K9me3 binding decreased in KvDMR, 
Rasgrf1, Airn and Inpp5fV2 ICRs, reflecting their methylation status. On the contrary, no reduction of ZFP57 and 
H3K9me3 binding occurs at the Gnas ICR, which did not show loss of DNA methylation in OP-mESCs (Figs 4a,b 
and S2h,i). Gapdh was used as negative control region and showed low levels of enrichment across all conditions 
as expected (Fig. 4a,b). Similar results were obtained in GS1 mESCs. GS1 OP-mESCs were characterized by loss of 
ZFP57 and H3K9me3 recruitment at KvDMR, Rasgrf1, Airn, but not at Inpp5fV2, which was already de-methylated 
in GS1 YP-mESCs (Figs S4a,b and S2k). These data show that ZFP57 and H3K9me3 ChIP levels are decreased at 
hypomethylated ICRs, consistently with the methylation profiles shown previously (Figs 2h–j, 3g and S2h,k).
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Figure 3. β-catenin overexpressing mESC clones maintain high Wnt/β-catenin activity and normal ICR 
methylation level after several in vitro passages. (a) Scheme showing how β-catenin overexpressing mESC 
clones (S33Y #1, #2) were obtained and grown. (b) Representative FACS-plot showing the percentage of positive 
mESCs for 7TGP topflash reporter activity in YP-mESCs, OP-mESCs, OP-S33Y #1 and OP-S33Y #2 mESC 
clones. The non infected (NI) cells were used as negative control (Ctrl-). The FITC and the Per-CP-Cy5.5-A 
detectors were used to identify GFP +(y axis) and autofluorescence (false positive) cells (x axis). The number 
of recorded events spans from 12000 (OP-mESC) to 18000 (YP-mESCs). Data are represented as means of 
n = 3 independent experiments ± SD. (c) Quantitative real-time PCR experiments showing the expression 
profiles of Axin2 in YP-mESCs, OP-mESCs, OP-S33Y #1 and OP-S33Y #2 mESC clones. The transcriptional 
levels are normalized to Gapdh as a reference gene. Data are represented as fold change (2−ΔΔCt) relative to the 
YP-E14 mESCs and the results are means of n = 3 independent experiments ± SE. Asterisks indicate statistical 
significance calculated by unpaired two-tailed t test analysis (n.s. not significant; ***p < 0.001). (d) Western 
blot analysis showing total β-catenin protein levels in E14 YP-mESCs, OP-mESCs, OP-S33Y #1 and OP-S33Y #2 
mESC clones and its quantification. Data are represented as fold change over the protein amount in YP-mESCs 
and means of n = 3 independent experiments ± SE. β-tubulin was used as loading control. For western-blot 
quantification densitometric analysis was carried out by using ImageJ software. The quantification reflects 
the relative amounts as a ratio of each protein band relative to their loading control. (e) Cluster analysis of the 
four different mESCs. For each line 2 different biological replicates were represented. (f) Box-plot, from min–
max values, showing the distribution of mCpG levels at ICRs in OP-S33Y #1 and OP-S33Y #2 mESC clones 
determined by RRBS analysis. The plots indicate the first quartile, median (black line) and third quartile. Data 
are obtained from the average of n = 2 biological replicates. (g) Heat-map representation of ICR methylation 
levels in YP-mESCs, OP-mESCs, OP-S33Y #1 and OP-S33Y #2 mESC clones.
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β-catenin and KAP1 proteins share common genomic bound regions. Having observed the effect 
of the Wnt/β-catenin signaling downregulation, we wondered whether β-catenin could play a direct or indirect 
role in the control of the ICR methylation and epigenetic changes. By analyzing published ChIP-sequencing data-
sets we observed that several β-catenin binding sites localized close to KAP1, which is responsible for the recruit-
ment of repressors in silent genomic regions. In particular, we compared published β-catenin ChIP-sequencing 
profiles73 with those of KAP131. We first overlapped ChIP-sequencing profiles between Biotin-tagged and 
Flag-tagged β-catenin, and we found 9113 common peaks (almost 69% of all peaks) (Fig. 4c, upper diagram), 
confirming the previously published results73. Next, we intersected these 9113 peaks with KAP1 ChIP-sequencing 
Figure 4. β-catenin and KAP1 share intergenic common DNA binding sites localized mainly on LTRs and 
ERVs. (a,b) Representative ChIP-qPCR experiment (out of n = 2 independent experiments) of ZFP57 (a) and 
H3K9me3 (b) recruitment at several ICRs. The data are represented as fold change (2−ΔΔCt) over IgG (a) or 
H3 (b) and means ± SD. (c) Venn diagram showing overlapping regions between ChIP-sequencing profiles 
of β-catenin and KAP1. The peaks between Flag- (β-catenin-Flag) and Biotin- (β-catenin-Biotin) tagged 
endogenous β-catenin published by Zhang and colleagues73 were intersected among them. The common 
bound regions were then overlapped with KAP1 ChIP-sequencing peaks performed in BJ1 mESCs by Anvar 
and colleagues31. (d) Bar chart showing genomic distribution of unique and common peaks among β-catenin, 
KAP1, H3K9me3, H3K4me3. (e) Bar chart showing ChIP-sequencing peaks intersection among KAP1, 
β-catenin, KAP1, H3K9me3 and Repeat masker. The number of common overlapping peaks is indicated on the 
top of the bars. (f) Table showing the different LTR and ERV families represented as number (#) and percentage 
(%) over Repeat maskers (column 2, 3), the total number of common overlapping peaks between β-catenin and 
KAP1 in BJ1 (column 4, 5), the total number of common overlapping peaks among β-catenin, KAP1 in BJ1 and 
KAP1 in JB1 mESCs (columns 6, 7).
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profiles31 carried out using two different mESC strains (BJ1 and JB1 mESCs) and we found 2631 common over-
lapping regions between β-catenin and KAP1 in BJ1 mESCs (Fig. 4c, lower diagram). Since the number of total 
bound regions was much lower in KAP1 ChIP-sequencing dataset in JB1 mESCs (38713 versus 72535 for KAP1 
in BJ1 mESCs), we found less common regions bound by both β-catenin and KAP1 (Table S2). As expected, most 
of the common regions bound from both β-catenin and KAP1, were intergenic or within introns, around 64% 
and 30% respectively considering both KAP1 ChIP-sequencing data sets (KAP1 in BJ1 and JB1 mESCs) (Fig. 4d 
and Table S2).
In parallel, we observed that, among the overlapping peaks, around 400–500 regions were also enriched for 
either H3K9me3 or H3K4me3, which are associated to silent or active chromatin, respectively (Fig. S4c,d and 
Table S2). For these analysis, we used the already published ENCODE ChIP-sequencing data for H3K9me3 
(GSM1000147) and H3K4me3 (GSM769008)74. As expected, the H3K9me3 peaks were located mostly within 
intergenic genomic regions, while the H3K4me3 bound sites were distributed among intergenic, introns and 
promoters, including CpG islands (Figs 4d, S4e and Table S2). Nevertheless, in the overlapping regions among 
β-catenin, KAP1 and H3K9me3 we could find only two ICRs (Grb10 and Meg3), as potential targets of β-catenin. 
Notably, the same two ICRs were also bound by ZPF5731, which specifically binds to methylated ICRs, as we 
previously observed in the overlapping regions between β-catenin and ZFP57. However, in this case, the total 
number of common binding sites was very low (Table S2).
Interestingly, almost all common genomic regions, bound by β-catenin and KAP1 were enriched in repeats 
(94% and 97% considering KAP1 datasets carried out in BJ1 and JB1 mESCs, respectively). This was also true 
when we overlapped the data with H3K9me3 peaks (Fig. 4e and Table S2). Among the different repeats the most 
enriched were the LTRs, which constitute 40% of the common regions bound by β-catenin and KAP1 (Fig. S4f 
and Table S3). Accordingly, 78–79% of the LTRs bound by both β-catenin and KAP1 were located within inter-
genic regions (Fig. S4g), confirming the previous data, showed in Fig. 4d and Supplementary Table S2.
Long-terminal repeat (LTR) elements belong to the third repeat class and represent 10% of all mammalian 
transposable elements75,76. All mammalian LTRs derive from the vertebrate-specific endogenous retroviral ele-
ments (ERVs), which can be grouped into sub-classes (I–III) and subfamilies, such as murine retroviral-related 
sequences (MURRSs, class I), ERVK, class II, ERVL and mammalian apparent LTR retrotransposons (MaLR, 
(class III), and others75–77. The expression of retroelements has been previously detected in different develop-
mental stages. However, in most tissues and during embryo development the transcription of ERVs is coun-
teracted by several epigenetic mechanisms, including DNA methylation, chromatin repressors (i.e. KAP1) and 
heterochromatin-associated histone marks, such as H3K9me346,78–80.
As expected most of the LTRs were found in the overlapping common regions between β-catenin and KAP1 
corresponded to endogenous retroviral elements, with the ERVK family (including Intracisternal A-particle (IAP) 
and early transposons (ETn//MusD)) being the most represented one, followed by MaLR and ERV1 families 
(Fig. 4f). Accordingly, almost 80% and 17% of ERVs were located within intergenic genomic regions and introns, 
respectively (Fig. 5a).
β-catenin can directly interact with KAP1 protein and regulate the expression of retrotransposons. 
To further investigate the epigenetic changes in YP- and OP-mESCs, we also analyzed the expression of some 
endogenous retroviruses, along with ICR DNA methylation. IAP and MusD subsets of ERVs were significantly 
upregulated in the E14 OP-mESCs (Fig. 5b, upper panel) but not MERVL, when compared to YP-mESCs. 
Interestingly, IAP expression increases also in GS1 OP-mESCs (Fig. 5b, lower panel), suggesting that these endog-
enous retroviral elements could be more active in OP- than in YP-mESCs.
Retrotransposons (such as IAP and MusD) are located within repressed genomic regions and they have been 
associated with induction and spreading of heterochromatin marks, such as H3K9me381. Furthermore, they 
are controlled by KAP1-mediated repressive complexes, which prevent their activation and genomic spread-
ing46,79,80. Therefore, to analyze whether the transcriptional up-regulation of the ERVs in OP-mESCs correlates 
with loss of heterochromatin marks, we performed ChIP- qPCR analysis for H3K9me3 in E14 and GS1 YP- and 
OP-mESCs. The recruitment of H3K9me3 decreased at IAP LTR in both E14 and GS1 OP-mESCs, and at MusD 
in E14 OP-mESCs (Fig. 5c upper and lower panels), which was consistent with their expression profile. However, 
the ChIP-qPCR profile did not follow MERVL expression changes, suggesting that other repressive mechanisms 
control specifically these elements in the OP-mESCs (Fig. 5b,c). In mESCs the expression of ERVs is controlled 
by a number of chromatin repressive factors, including KAP1, DNMT1, among others82. In particular, KAP1 
acts as a co-repressor by facilitating the recruitment of repressive complexes at ERVs, ICRs or other silenced 
genomic regions46. Since, in our analysis almost all of the common overlapping regions corresponded to inter-
genic regions enriched in LTRs, we reasoned that β-catenin could interact with the chromatin repressive complex, 
in particular with KAP1. To confirm this hypothesis, we performed co-immunoprecipitation (CoIP) experiments 
in E14 YP-mESCs carrying either a short hairpin against a control sequence with no predicted genomic target 
(shCtrl) or against β-catenin (shβcat). In shCtrl-transduced mESCs, β-catenin was co-immunoprecipitated with 
KAP1 and DNMT1, suggesting that it can interact with each one of the components of the epigenetic repres-
sive complex (Fig. 5d, left panel). As control, we performed CoIP experiments in the shβcat-infected mESCs. In 
absence of β-catenin neither KAP1 nor DNMT1 could be immunoprecipitated as expected (Fig. 5d, right panel). 
Importantly, the amount of total (as observed by the input band) and the immunoprecipitated β-catenin was 
much lower in the shβcat-infected mESCs, showing the high silencing efficiency (Fig. 5d, right panel).
Inhibition of β-catenin causes impaired mESC differentiation and changes in retrotransposon 
expression, but it does not affect ICR methylation. To further investigate whether β-catenin plays a 
direct role in protecting ICRs and retrotransposons, thereby safegarding genomic stability, we knocked down 
β-catenin in E14 YP-mESCs by using three different pLKO-based silencing constructs83,84. We tested β-catenin 
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silencing efficiency by performing qPCR and by western blot analysis. β-catenin transcript and protein (both 
total and nuclear) were efficiently downregulated (Fig. 6a, upper panel, and 6b), as well as the downstream target 
Axin2 (Fig. 6a, upper panel). Neither the expression of pluripotency markers, Nanog and Oct4 (Fig. 6a, lower 
panel), nor the self-renewal capacity (Fig. 6c, left micrographs) were impaired after β-catenin silencing in mESCs 
as expected14,85. Nevertheless, mESCs carrying β-catenin silencing shRNAs could not properly differentiate. The 
embryoid bodies started to disaggregate already at day 3 (Fig. 6c), displaying a phenotype similar with the one 
reported in β-catenin knockout mESCs thus confirming the already published data14,85.
When we analyzed DNA methylation profile by RRBS, we did not observe a drastic loss of genome-wide 
DNA methylation at CpG islands and ICRs, in contrast to what we observed for OP-mESCs (Fig. S5a,b, and 
Table S4). We performed RRBS analysis on both shCtrl- and shβcat- transduced mESCs and EBs at day 8 of 
Figure 5. β-catenin interacts with the chromatin repressive complex. (a) Table showing genomic annotation 
of common ERVs bound by β-catenin and KAP1 in BJ1 (columns 2, 3), and among β-catenin, KAP1 in BJ1 
and KAP1 in JB1 mESCs (columns 4, 5), represented as number (#) and percentage (%) over the total common 
peaks. (b) Quantitative real-time PCR experiments showing the expression profiles of ERVs (IAP, MusD, 
MERVL) in E14 (upper charts) and GS1 (lower charts) YP- and OP- mESCs. The transcriptional levels are 
normalized to Gapdh as a reference gene. Data are represented as fold change (2−ΔΔCt) relative to the YP-
mESCs and the results are means of n = 3 independent experiments ± SE. (c) ChIP-qPCR analysis of H3K9me3 
recruitment at IAP, MusD and MERVL ERVs in E14 (upper charts) and GS1 (lower charts) YP- and OP- mESCs. 
The data are represented as fold change (2−ΔΔCt) over H3 and means of n = 3 independent experiments ± SE.  
(b,c) Asterisks indicate statistical significance calculated by unpaired two-tailed t test analysis (n.s. not 
significant; *p < 0.05; **p < 0.01). (d) Co-immunoprecipitation of β-catenin with either KAP1 or DNMT1 
followed by western-blot analysis, in shCtrl -or shβcat- transduced E14 mESCs. 10% of input was used for 
DNMT1, KAP1 and β-catenin IP. IgG were used as negative control. An empty well was included between each 
experimental condition (Input, IgG and IP) to avoid cross-contamination.
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differentiation. We focused on the mESCs carrying shβcat #1 construct, which showed the highest silencing 
efficiency. Shβcat-infected mESCs displayed lower methylation at Peg10, Peg3, Inpp5fV2, Airn (Fig. S5b, black 
arrows), whereas Snrpn, Commd1 and Impact had less methylation in the shβcat-transduced EBs, when compared 
to control (shCtrl) (Fig. S5b, blue arrows). Moreover, we validated the RRBS data by performing COBRA analysis 
on several ICRs, such as Airn, Grb10, Rasgrf1, Ig-DMR, Peg10 and Gnas XL. The methylation profile (as showed by 
the enzymatic digestion pattern) did not almost change between shCtrl- and shβcat-transduced mESCs (Fig. S5c), 
suggesting that the methylation differences observed in the RRBS analysis were small and not comparable to 
the ones observed in OP-mESCs. Nevertheless, we observed an upregulation of IAP, MusD, but not of MERVL 
Figure 6. β-catenin silencing impairs mESC differentiation. (a) Quantitative real-time PCR analysis showing 
β-catenin silencing efficiency, Axin2 and pluripotency marker (Nanog, Oct4) levels. The transcriptional levels 
are normalized to Gapdh as a reference gene. Data are represented as fold change (2−ΔΔCt) relative to the 
shCtrl-infected mESCs and the results are means of n = 3 technical replicated ± SD. (b) Western blot analysis 
showing protein levels of total and nuclear β-catenin in shCtrl-, shβcat#1-, shβcat#2- and shβcat#3- transduced 
E14 mESCs (n = 1). Quantification of total and nuclear β-catenin is represented as relative to total β-catenin 
in shCtrl-transduced mESCs. β-tubulin and H3 were used as loading controls. For western-blot quantification 
densitometric analysis was carried out by using ImageJ software. The quantification reflects the relative amounts 
as a ratio of each protein band relative to their loading control. (c) Representative bright field images of mESCs 
and embryoid bodies (EBs) at day 3 (D3), 8 (D8) after β-catenin silencing (shβcat #1, #2, #3) versus the control 
condition (shCtrl). Scale bar is 400 μm. (d) Quantitative real-time PCR experiments showing the expression 
profiles of ERVs (IAP, MusD, MERVL) in shCtrl-, shβcat#1-, shβcat#2- and shβcat#3- transduced E14 mESCs. 
The transcriptional levels are normalized to Gapdh as a reference gene. Data are represented as fold change 
(2−ΔΔCt) relative to shCtrl-infected mESCs and are means of n = 3 independent experiments ± SE. Asterisks 
indicate statistical significance calculated by unpaired two-tailed t test analysis (n.s. not significant; *p < 0.05; 
**p < 0.01). (e) Schematic representation showing cellular and epigenetic changes occurring in prolonged in 
vitro mESC cultures along with Wnt/β-catenin pathway downregulation.
www.nature.com/scientificreports/
1 2Scientific RepoRts |           (2019) 9:948  | https://doi.org/10.1038/s41598-018-37442-5
expression after β-catenin silencing (Fig. 6d) suggesting that β-catenin silencing might affect the epigenetic regu-
lation of silent genomic regions, likely acting together with repressive complexes. In conclusion, the observation 
that β-catenin removal did not cause relevant changes in DNA methylation might indicate that the endogenous 
β-catenin amount is already limiting and further reduction does not affect the methylation level.
Discussion
Since mouse embryonic stem cells (mESCs) were isolated, in the early 80’s6,7, many groups started to investigate 
the mechanisms that define their pluripotency. Mouse ESCs present many comparable properties with the inner 
cell mass (ICM) of the blastocyst, such as the expression of pluripotency genes and the capacity to contribute 
to the formation of the three germ layers. Up to now, many studies have investigated embryonic developmental 
mechanisms by exploiting the capacity of mESCs to self-renew in vitro indefinitely. Mouse ESCs are usually cul-
tured in vitro in the presence of LIF86,87, which directly controls the expression of the pluripotency gene-network 
that includes Oct4, Nanog and other factors88.
Nevertheless, whether the in vitro cultured mESCs are identical to the ICM has been a topic of debate of the 
last years. With the aim to obtain mESCs with features as much as possible similar to the ICM, the 2i-LIF cultur-
ing medium was designed to drive mESCs toward a naïve pluripotent state, characterized by high expression of 
several pluripotency genes, including Rex189,90. This has been attributed to the activity of two small drug inhib-
itors (2i) of MEK1/2 and GSK3β, the latter leading to Wnt/β-catenin signaling activation. However, the identity 
of mESCs is not only dependent on the pluripotency gene network but also on the maintenance of a correct 
epigenetic state. Indeed, many groups previously observed genomic instability of mouse and human ESCs when 
they were cultured in vitro for a long time36. Recently, it has been shown that the constant inhibition of MEK1/2 
is detrimental for mESC homeostasis after prolonged in vitro culture, leading to chromosomal aberrations, severe 
global hypomethylation and impaired differentiation capacity39. However, this study did not addressed whether 
Wnt/β-catenin activity also had an epigenetic effect in prolonged mESC cultures.
The essential role of Wnt/β-catenin signaling in mESC differentiation is widely accepted. Loss of β-catenin12–14 
or Wnt3a17,91 causes embryo cell death when gastrulation starts. Likewise, we observed that OP-mESCs, which 
showed decreased endogenous Wnt/β-catenin activity, could not generate beating embryoid bodies with the same 
efficiency as YP-mESCs. On the contrary, they expressed high levels of ectodermal markers, such as Otx2, Sox1, 
Pax6, Nestin and III β-Tubulin, during both EB and neural differentiation. E14 OP-mESCs also expressed high 
levels of Fgf5 during differentiation, but GS1 OP-mESCs did not, suggesting a possible epigenetic dysregulation 
of this gene in this strain. Since the differentiation potential of OP-mESCs was biased toward the ectodermal fate, 
these data might suggest that OP-mESCs could be more primed with respect to the YP-mESCs, and they could 
share some common features with epiblast stem cells (EpiSCs)92,93. It is important to note however that EpiSCs 
were shown as able to generate the three germ layers in vitro and maintain their genomic integrity93. In our study, 
the expression level of pluripotency genes was maintained high in OP-EBs, indicating that OP-mESCs could not 
properly exit from pluripotency state, in agreement with what was previously observed in β-catenin knockout 
mESCs85. Indeed, β-catenin knockout–derived teratomas displayed high level of pluripotency markers and fea-
tures comparable to germ cell tumors.
In addition to molecular pathways alterations, several epigenetic changes have been investigated in both 
mouse and human ESCs. These epigenetic changes can occur both at the level of DNA methylation and histone 
modifications and they affect the chromatin structure and ESC identity. In particular, DNA methylation is sensi-
tive to external stimuli and cellular stress. DNA methylation pattern is maintained stable during cell replication 
through the action of DNA methyltransferases (DNMTs) and other repressors, since tuned methylation levels are 
indispensable for mESC stability and differentiation. Loss of DNMTs leads to severe global epigenetic deregula-
tion, which causes developmental defects and embryonic lethality, as previously reported39,44,94–96. Accordingly, in 
our study, we observed changes in DNA methylation at several CpG enriched genomic regions, which were prev-
alently hypomethylated upon prolonged culturing, and consequently, impaired mESC differentiation potential. 
Moreover, the hypomethylated CpG regions appeared to control several biological processes as indicated by the 
gene ontology analysis, with the metabolic processes as the most represented. Additionally, some of the analyzed 
hypomethylated regions were found nearby genes that have been previously reported to interact with Wnt path-
way and its downstream components in different cellular contexts97–101. Some of these genes have been described 
to inhibit Wnt/β-catenin signaling pathway, such as Grb10, Kdm2b, Tet3, Pcdhgc5, Mir148a97–101. On the contrary, 
other hypomethylated regions corresponded to genes that act as activators or inhibitors of Wnt signaling, depend-
ing on the molecular and cellular context, such as Runx3, En1, Nkx6-1, Epha2, Nr4a102–107.
In particular, the OP-mESCs showed high hypomethylation at the level of imprinted genes, which commonly 
show stable allele-specific methylation pattern in the pre-implantation embryo. It is important to take into con-
sideration that the imprinted genes are organized in clusters with a common ICR. Methylation changes of one 
ICR can affect the expression of many imprinted genes within the cluster (around 4–5). In this study, we observed 
that the YP-mESCs show 50% of methylation at many ICRs, indicating that allele specific methylation was lost 
in prolonged cultures, extended to both maternally and paternally imprinted loci. Additionally, the OP-mESCs 
were characterized by higher retrotransposon expression, such as IAP, when compared to YP-mESCs. Both 
imprinted genes and retrotransposons are tightly epigenetically controlled27,31–34,45,46,79–81 since they play essential 
roles during embryonic and extra-embryonic tissue formation. Loss of imprinting or transcriptional changes in 
retrotransposons, in particular in IAP, could indeed be detrimental to genomic stability and embryo develop-
ment26,36,39,40,94,96,108,109. Accordingly, both E14 and GS1 OP-mESCs could not properly differentiate when com-
pared to YP cells.
OP-mESCs were characterized by significantly faster cell cycle progression with respect to YP-mESCs, sug-
gesting that the epigenetic changes could also affect cell cycle check-points. Interestingly, loss of methylation at 
the KvDMR ICR has been associated with lower expression of the cell cycle inhibitor cyclin-dependent kinase 
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inhibitor 1 C, (Cdkn1c)110. In addition, Wnt/β-catenin pathway has been reported to have an anti-proliferative 
effect, by directly regulating the expression of cell cycle repressor genes61, thus safeguarding mESC identity. In 
line with previous published studies, we observed that both E14 and GS1 mESCs downregulated the expression 
of Wnt downstream targets (Axin2, Lef1, Tcf1, Sp5) and β-catenin protein at late passages. Wnt activity reduction 
was not associated with altered pluripotency gene expression, but it was translated into impaired differentiation 
potential, faster cell cycle progression and genomic instability, thus loss of mESC homeostasis. The factors caus-
ing Wnt/β-catenin pathway downregulation in prolonged cell cultures still remain unknown. Among possible 
triggering events, oxidative stress could be a putative inducing factor. Indeed, increased oxidative stress has been 
reported to antagonize Wnt signaling and has been previously described to induce genomic aberrations and loss 
of cell homeostasis in long-term in vitro cell culture111–114. In particular, increased oxidative stress can antag-
onize Wnt signaling by inducing expression of Forkhead box-O (FOXO) transcription factor115. FOXO com-
petes with TCFs for its interaction with β-catenin, thus inhibiting TCF transcriptional activity and the canonical 
Wnt/β-catenin signaling pathway116,117. Additionally, among the hypomethylated regions analyzed by RRBS we 
found some inhibitors of Wnt/β-catenin pathway, including Kdm2b, which inhibits the stability of β-catenin pro-
tein98, thereby creating a feedback loop that could accelerate β-catenin degradation.
It is important to note that different mESC lines can display disparate endogenous levels of Wnt/β-catenin 
activity, due to either the diverse in vitro culturing conditions or different timing of mESC isolation from the 
embryo20,62. YP-GS1 mESCs showed low levels of nuclear β-catenin protein, if compared to the YP-E14 mESCs. 
Interestingly, ICRs, such as Inpp5fV2 region were hypomethylated in GS1 mESCs already at early passages, sug-
gesting that this cell line was less stable with respect to E14. The role of Wnt activity in homeostasis mainte-
nance has been largely described in the adult stem cells. For instance, long-term hematopoietic stem cells show a 
decrease in the canonical Wnt/β-catenin signaling activity during ageing118. In parallel, other studies has reported 
that many epigenetic changes, including loss of imprinting, occur in hematopoietic and other adult stem cell com-
partments119. The observation that mESCs carrying gain of function Wnt mutants (S33Y-β-cat #1 and S33Y-β-cat 
#2) maintained normal or even higher level of methylation at the ICRs also after prolonged in vitro culturing, 
further strengthen the hypothesis of a possible “protective” role due to Wnt/β-catenin pathway, which can control 
epigenetic stability. Even after prolonged culturing, these clones retained Wnt/β-catenin activity and methylation 
at similar levels of YP-mESCs. However, it is important to take into account that additional epigenetic changes 
might occur in some of the clones, due to stochastic perturbations. Indeed, some of the ICRs, such as Peg10, Gpr1 
were hypomethylated in the OP-S33Y-β-cat #2 mESC clone, whereas others showed an increase in DNA methyl-
ation level in both β-catenin mutant clones. However, in both β-catenin overexpressing clones the overall DNA 
methylation profile was similar to the YP-mESCs.
Finally, we observed that β-catenin interacts with KAP1 and DNMT1 repressors, therefore it can be consid-
ered as a regulator of epigenetic stability maintenance. By analyzing published ChIP-sequencing datasets we 
observed that β-catenin and KAP1 share common target regions, located within intergenic regions and over-
lapping with endogenous retroviral elements. These data further strengthen the conclusion that β-catenin could 
mediate the action of repressors recruited by KAP1 on silent genomic regions, even though the potential mech-
anism still remains unknown. Interestingly, β-catenin protein has been previously described to interact with 
DNMT1 in colorectal cancer cells120 or with other chromatin factors in mESCs121. However, it is important to note 
that, when we silenced β-catenin in mESCs we did not detect drastic methylation changes at the ICRs, though 
shβcat- transduced cells upregulated the transcriptional levels of IAP and MusD endogenous retroviruses. These 
data suggest that either the endogenous levels of β-catenin are already limiting and its further decrease does not 
impair methylation maintenance, or, alternatively, that β-catenin does not directly act on the ICRs but it acts as a 
mediator for the repressive complexes. Up to date, the factors causing genomic instability in mESCs are not clear, 
even though many chromatin modifiers have been described to act on repressed genomic regions.
All in all, our data suggest that Wnt/β-catenin activity need to be maintained constantly active in mESCs 
during passages to ensure correct cell identity and epigenetic stability. Loss of Wnt activity results in global hypo-
methylated DNA, loss of chromatin repressor recruitment and activation of silent genomic regions, resulting 
in impaired mESC differentiation and altered cell cycle progression (Fig. 6e). Sustained activation of the Wnt 
signaling pathway results in maintenance of methylation at most of the ICRs after prolonged in vitro culture. In 
conclusion, Wnt/β-catenin pathway, mediates a large number of molecular and biological processes including 
DNA methylation at ICRs to ensure correct cell and tissue homeostasis.
Materials and Methods
Cell lines and differentiation protocols. GS-1 (129 Sv) and E14 (129/Ola) mouse embryonic stem cells 
(mESCs) were obtained from Merrill’s laboratory122 and purchased from ATCC, respectively. Both mESC cell 
lines were maintained in 0.1% gelatin (Millipore ES-006-B)-coated plates mESC medium, which consisted of 
DMEM supplemented with 15% fetal bovine serum (FBS), L– glutamine (2 mM), penicillin (100 U/ml), strepto-
mycin (100 µg/ ml), sodium pyruvate (1 mM), non-essential amino acid (NEAA) (0,1 mM), 2-mercaptoethanol 
(0,5 mM) and ESGRO mLif (1000 U/ml). E14 mESCs were thawed at passage 8 and expanded up to passage 14 for 
the analysis of young passage (henceforth called YP-E14 mESCs) E14 mESCs. GS1 were thawed from passage 18 
and expanded up to passage 22 for the analysis of young passage (henceforth called YP-GS1 mESCs) GS1 mESCs. 
To obtain the old passage (henceforth called OP-mESCs) E14 and GS1 mESCs were kept in culture for ~70 
and ~50 passages, respectively, in mESC medium. At each passage cells were detached by using trypsin (0.025% 
trypsin and 0.04% EDTA, SIGMA 25300-054) at 37 °C, centrifuged for 5 minutes and 300 rcf and plated with a 
dilution ratio of 1:15–1:20 at each passage.
The differentiation medium for the production of embryoid bodies (EBs) consisted of mESC culture medium 
without LIF. The cells were harvested by trypsinisation, counted, and propagated in hanging drops (400 single 
mESCs/30 µl initial drop) for 2 days, before being transferred to 10 cm2 bacterial dishes, where the cells grow in 
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suspension. On day 5, the embryoid bodies were transferred onto gelatinized p100 dishes always in differentiation 
medium, which consisted of mESC culture medium without the LIF. The medium was changed every 2 days and 
the beating embryoid bodies were observed starting from day 8 of the differentiation process. For expression pro-
file analysis the cells were harvested and pelleted at day 0 (ESC), 6 and 12 of the differentiation process.
For neural differentiation in monolayer, undifferentiated mESCs were gently dissociated using trypsin (0.025% 
trypsin and 0.04% EDTA, SIGMA 25300-054) at 37 °C and plated onto 0.1% gelatin-coated tissue culture plastic at a 
density of 0.5–1.5 × 104/cm2 in N2B27 medium [1:1mix of DMEM/F12 (GIBCO) supplemented with N2 (GIBCO) 
and Neurobasal medium (GIBCO) supplemented with B27 (GIBCO)], L–glutamine (0,5 mM), 2-mercaptoethanol 
(0,1 mM) and retinoic acid (1 μM). The medium was refreshed every other day64,65. For expression profile analysis 
cells were detached by using Accutase (A1110501, GIBCO) and pelleted at 300 rcf for 5 minutes.
Total protein extraction. Cells were trypsinized (0.025% trypsin and 0.04% EDTA, SIGMA 25300-054) 
at 37 °C, pelleted at 300 rcf and washed twice with PBS. During each wash cells were pelleted at 300 rcf for 5 min 
4 °C. Cell lysis was performed on ice for 25 min, in RIPA buffer (150 mM NaCl, 1% Nonidet P40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris-HCl, pH 8.0) containing protease (SIGMA P8340) and 
phosphatase inhibitors (SIGMA P2850). Insoluble material was pelleted by centrifugation at 16,000 rcf for 30 min 
at 4 °C. Protein concentrations were determined using the Bradford assay (Bio-Rad 500-0006). Western blot was 
performed as specified in the apposite section with the antibodies indicated in Table S6.
Nuclear protein extraction. For nuclear protein extraction cells were trypsinized (0.025% trypsin and 
0.04% EDTA, SIGMA 25300-054) at 37 °C, pelleted at 300 rcf and washed twice with cold PBS. During each wash 
cells were pelleted at 300rcf for 5 min at 4 °C. Cells were incubated in hypotonic buffer (10 mM Tris-HCl pH 7.8, 
5 mM KCl, 2 mM MgCl2 DTT 1 mM) containing protease inhibitors (SIGMA P8340) for 10 min at 4 °C. Cells 
were pelleted at 300 rcf for 5 min at 4 °C and plasma membrane lysis was performed in 0,25% NP-40 hypotonic 
buffer on ice for 15 min. Nuclei were pelleted at 300 rcf for 15 min at 4 °C and washed twice in hypotonic buffer. 
Isolated nuclei were incubated in RIPA buffer (150 mM NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1% 
sodium dodecyl sulphate, 50 mM Tris-HCl, pH 8.0) containing protease (SIGMA P8340) and phosphatase inhib-
itors (SIGMA P2850). Insoluble material was pelleted by centrifugation at 16,000 rcf for 30 min at 4 °C. Protein 
concentrations were determined using the Bradford assay (Bio-Rad 500-0006). Western blot was performed as 
specified in the apposite section with the antibodies indicated in Table S6.
protein immunoprecipitation. For each immunoprecipitation condition 50 µl of Dynabeads (Thermo sci-
entific 10004D) were washed 3 times in 500 µl of cold CHAPS buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 0.15% 
CHAPS) containing protease inhibitors (SIGMA P8340). To separate the beads from the wash solution the tubes 
were placed on the magnet. The isolated beads were re-suspended in 500 µl of antibody solution containing 8 µg of 
antibody (DNMT1 (Abcam, ab87656) β-catenin (Millipore, 06-734) KAP1 (Abcam, ab10483),) or IgG (Abcam, 
ab46540) in cold CHAPS buffer containing protease inhibitors) and incubated O/N at 4 °C on a rotating wheel.
Cell fractionation and nuclei isolation was performed as described in the previous paragraph. For 
co-immunoprecipitation experiments, nuclei were lysed in CHAPS buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 
0.15% CHAPS containing protease inhibitors) for 15 min at 4 °C and were immerged in liquid nitrogen for 2 min 
and successively thawed on ice to perform a freeze-thaw lysis. Insoluble material was pelleted by centrifugation 
at 16,000 rcf for 30 min at 4 °C and the supernatants (100 µg of the nuclear protein extract) were incubated with 
antibody-coupled dynabeads overnight O/N at 4 °C. Beads were washed three times with CHAPS buffer contain-
ing protease inhibitors and elution was performed by boiling beads in Laemmli buffer (1x) at 95 °C for 10 min. 
Western blot was performed as specified in the apposite section with the antibodies indicated in Table S6.
Western blot. Either total protein extract or nuclear protein extract was mixed with 4 × Laemmli buffer (40% 
glycerol, 240 mM Tris/HCl, pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% β-mercaptoethanol) and denatured 
at 99 °C for 10 minutes. Either total protein extract or nuclear protein extract, or co-immunoprecipitation eluate 
was separated by SDS-PAGE, and transferred to poly vinylidene difluoride membrane (BIO-RAD 162-0177). The 
membranes were blocked with 5% non-fat dry milk (SIGMA 70166) in TBS-Tween 20 (0,1%) (SIGMA P1379) for 
60 min, incubated with primary antibodies (β-catenin (BD, 610153), NANOG (Calbiochem, #SC1000), OCT-4 
(Santa Cruz, sc-5279), β-tubulin (SIGMA, T0198), DNMT1 (Abcam, ab87656), KAP1 (Abcam, ab10483)) over-
night at 4 °C. The working dilution of each antibody is listed in Table S6. The poly vinylidene difluoride membrane 
was then washed three times with TBS-T for 15 min, incubated with the peroxidase-conjugated secondary anti-
body (1:2000, Amersham Biosciences NA931 (Mouse IgG) and NA934 (Rabbit IgG)) in TBS-T with 5% non-fat 
dry milk for 60 min, and washed three times with TBS-T for 10 min. Immunoreactive proteins were detected 
using Pierce ECL Western Blotting Substrate (Thermo Scientific 32106). Densitometric analysis was carried-out 
by using ImageJ software. The quantification reflects the relative amounts as a ratio of each protein band relative 
to their loading control.
Reduced representation bisulfite sequencing (RRBS) data analysis. Reads were processed by adap-
tor trimming (Illumina Pipeline Casava v1.8.2), filtered for low quality reads (Trim Galore v0.2.8) and subjected 
to quality control (FastQC). Reads were aligned using Bismark v0.7.9124 to the Mus musculus genome (assembly 
NCBI37/mm9). CpG methylation calls were extracted using the Bismark methylation extractor v0.7.9. The meth-
ylation level of a DNA region was defined using SeqMonk v0.32.1 pipeline (Simon Andrews, Babraham Institute, 
UK) considering at least 2 CpGs covered by at least 10 reads. Hypomethylated DNA regions were identified by 
searching for sequences with common symmetric CpGs (at least 10 CpGs covered by at least 10 reads that were 
less than 2 kb apart) with a decrease in methylation of >25%. Clustering and correlation analysis were performed 
using R package methylKit125. The RRBS data are available under the GSE109417 accession number.
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Analysis of published ChIP-seq data sets. The CpG islands data was downloaded from the UCSC 
genome annotation data-base for the July 2007 assembly of the mouse genome (mm9, NCBI build 37). The 
repeat types and coordinates were extracted from the RepeatMasker file (UCSC table browser). We used bed-
tools (v2.25.0)126 to overlap ChIP-seq peak data coordinates. The annotatePeaks tools from HOMER suite of 
programs127 was used to annotate the resulting peak overlaps (using mm9 version of Mus musculus genome 
assembly).
Relevant figures were produced in the R environment using mainly ggplot2128, reshape2129 VennDiagram130 
and UpSetR131 packages.
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